Khan, Zahra Rafiqa (2024) In silico discovery and in vitro validation of novel CDK5 and CDK9 inhibitors with glioblastoma therapeutic potential. Doctoral thesis, University of Central Lancashire.
Khan, Zahra Rafiqa, Welsby, Philip J., Stasik, Izabela ORCID: 0000-0002-7756-4731 and Hayes, Joseph ORCID: 0000-0002-7745-9616 (2024) Discovery of Potent Multikinase Type-II Inhibitors Targeting CDK5 in the DFG-out Inactive State with Promising Potential against Glioblastoma. Journal of Medicinal Chemistry, 67 (9). pp. 7539-7552. ISSN 0022-2623